Literature DB >> 9223469

Characterization of a BHK(TK-) cell clone resistant to postattachment entry by herpes simplex virus types 1 and 2.

R J Roller1, B C Herold.   

Abstract

BHK(TK-) cells selected for resistance to polyethylene glycol-mediated fusion give rise to clones that are resistant to herpes simplex virus (HSV) infection. We have characterized one such clone, designated 95-19, and found that it is resistant to entry of HSV type 1 (HSV-1), HSV-2, and the related alphaherpesvirus pseudorabies virus (PRV). Single-step growth experiments show no detectable replication of multiple strains of HSV-1 and HSV-2 on 95-19 cells. Three lines of evidence suggest that these cells are resistant to postattachment entry. (i) Measurements of binding of radiolabeled virus show that heparin-sensitive binding of HSV-1 and HSV-2 to 95-19 cells is identical to binding to BHK(TK-) cells, suggesting that the block to replication occurs after attachment to heparan sulfate proteoglycan. (ii) 95-19 cells exposed to HSV-1 or HSV-2 at high multiplicity show no detectable immediate-early (IE) mRNA expression. (iii) Exposure of attached virus and cells to polyethylene glycol results in partial recovery of both IE gene expression and virus yield in single-step growth. The degrees of recovery of single-step yield and IE gene expression are similar, suggesting that the only block to single-step replication is at the point of virus entry and that these cells are deficient in some cellular factor required for efficient postattachment entry of free virus. 95-19 cells are also highly resistant to entry by cell-to-cell spread, suggesting that the same cellular factor participates in both types of entry.

Entities:  

Mesh:

Year:  1997        PMID: 9223469      PMCID: PMC191835     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity.

Authors:  M Sarmiento; M Haffey; P G Spear
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

2.  Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family.

Authors:  R I Montgomery; M S Warner; B J Lum; P G Spear
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

3.  Initial interaction of herpes simplex virus with cells is binding to heparan sulfate.

Authors:  D WuDunn; P G Spear
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface.

Authors:  A O Fuller; P G Spear
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  Herpes simplex viruses lacking glycoprotein D are unable to inhibit virus penetration: quantitative evidence for virus-specific cell surface receptors.

Authors:  D C Johnson; M W Ligas
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

6.  Entry of herpes simplex virus 1 in BJ cells that constitutively express viral glycoprotein D is by endocytosis and results in degradation of the virus.

Authors:  G Campadelli-Fiume; M Arsenakis; F Farabegoli; B Roizman
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

7.  Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.

Authors:  S L Highlander; S L Sutherland; P J Gage; D C Johnson; M Levine; J C Glorioso
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

8.  Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion.

Authors:  W H Cai; B Gu; S Person
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

9.  Herpes simplex virus glycoprotein D mediates interference with herpes simplex virus infection.

Authors:  R M Johnson; P G Spear
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

10.  A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells.

Authors:  M W Ligas; D C Johnson
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

View more
  15 in total

1.  Mutations in herpes simplex virus glycoprotein D distinguish entry of free virus from cell-cell spread.

Authors:  D A Rauch; N Rodriguez; R J Roller
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression.

Authors:  J L Meier; J A Pruessner
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Herpesvirus entry mediator HVEM mediates cell-cell spread in BHK(TK-) cell clones.

Authors:  R J Roller; D Rauch
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

4.  Molecular umbrellas: a novel class of candidate topical microbicides to prevent human immunodeficiency virus and herpes simplex virus infections.

Authors:  Rebecca Pellett Madan; Pedro M M Mesquita; Natalia Cheshenko; Bingwen Jing; Vikas Shende; Esmeralda Guzman; Taylor Heald; Marla J Keller; Steven L Regen; Robin J Shattock; Betsy C Herold
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

5.  Mutations in herpes simplex virus glycoprotein D that prevent cell entry via nectins and alter cell tropism.

Authors:  Sharmila Manoj; Cheryl R Jogger; Dawn Myscofski; Miri Yoon; Patricia G Spear
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-23       Impact factor: 11.205

6.  Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection.

Authors:  Thessicar E Antoine; Yogendra K Mishra; James Trigilio; Vaibhav Tiwari; Rainer Adelung; Deepak Shukla
Journal:  Antiviral Res       Date:  2012-10-06       Impact factor: 5.970

7.  NP-1, a rabbit alpha-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2.

Authors:  Sara Sinha; Natalia Cheshenko; Robert I Lehrer; Betsy C Herold
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

8.  An investigative peptide-acyclovir combination to control herpes simplex virus type 1 ocular infection.

Authors:  Paul J Park; Thessicar E Antoine; Asim V Farooq; Tibor Valyi-Nagy; Deepak Shukla
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-27       Impact factor: 4.799

9.  Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread.

Authors:  Natalia Cheshenko; Marla J Keller; Veronica MasCasullo; Gary A Jarvis; Hui Cheng; Minnie John; Jin-Hua Li; Kathleen Hogarty; Robert A Anderson; Donald P Waller; Lourens J D Zaneveld; Albert T Profy; Mary E Klotman; Betsy C Herold
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

10.  Identification of cellular genes affecting the infectivity of foot-and-mouth disease virus.

Authors:  Maria E Piccone; Yanan Feng; Annie C Y Chang; Ronen Mosseri; Quan Lu; Gerald F Kutish; Zhiqiang Lu; Thomas G Burrage; Christina Gooch; Daniel L Rock; Stanley N Cohen
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.